Source: Medical Microbiology and Immunology. Unidade: FMRP
Subjects: VÍRUS DE DNA (CARACTERÍSTICAS;TRANSMISSÃO;DIAGNÓSTICO), VIROLOGIA, TRANSFUSÃO DE SANGUE
ABNT
SLAVOV, Svetoslav N. et al. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. Medical Microbiology and Immunology, v. 62, n. 3, p. 247-262, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1574-695x.2011.00819.x. Acesso em: 11 out. 2024.APA
Slavov, S. N., Kashima, S., Pinto, A. C. S., & Covas, D. T. (2011). Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. Medical Microbiology and Immunology, 62( 3), 247-262. doi:10.1111/j.1574-695x.2011.00819.xNLM
Slavov SN, Kashima S, Pinto ACS, Covas DT. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions [Internet]. Medical Microbiology and Immunology. 2011 ; 62( 3): 247-262.[citado 2024 out. 11 ] Available from: https://doi.org/10.1111/j.1574-695x.2011.00819.xVancouver
Slavov SN, Kashima S, Pinto ACS, Covas DT. Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions [Internet]. Medical Microbiology and Immunology. 2011 ; 62( 3): 247-262.[citado 2024 out. 11 ] Available from: https://doi.org/10.1111/j.1574-695x.2011.00819.x